Nivalon Medical Technologies Inc. Appoints Jared D. Ament, MD, MPH, FAANS, FACS as Chief Medical Officer
Hartford, Connecticut — May 22, 2026 — Nivalon Medical Technologies Inc., a medical technology company focused on next-generation patient-specific spinal implant systems, today announced the appointment of Jared D. Ament, MD, MPH, FAANS, FACS as Chief Medical Officer (CMO).
Dr. Ament is a board-certified, fellowship-trained neurosurgeon affiliated with Cedars-Sinai and the Neurosurgery & Spine Group in California. He is nationally recognized for his leadership in spinal motion preservation surgery, artificial disc replacement, minimally invasive spine procedures, and advanced neurosurgical technologies. Dr. Ament is widely known for advocating alternatives to traditional spinal fusion procedures and has become a leading voice in the advancement of motion-preserving spine surgery. Dr. Ament completed his neurosurgical residency at University of California Davis Health, a spine surgery fellowship at Cedars-Sinai Medical Center, and post-doctoral research training through Harvard Medical School. He also earned a Master of Public Health (MPH) degree focused on clinical effectiveness and outcomes research. As Chief Medical Officer, Dr. Ament will help lead Nivalon’s clinical strategy, surgeon engagement initiatives, product development, regulatory planning, and global clinical trial activities as the company advances its personalized lumbar total disc replacement platform toward commercialization.
“Nivalon is developing a fundamentally different approach to spinal motion preservation by combining advanced imaging, AI-driven surgical planning, patient-specific implant manufacturing, and advanced biomaterials,” said Todd Hodrinsky, CEO of Nivalon Medical Technologies Inc.. “Dr. Ament’s clinical expertise, leadership in motion preservation surgery, and commitment to innovation make him an ideal addition to our executive team as we move toward global clinical deployment.”
“I believe the future of spine surgery will be driven by technologies that preserve motion, restore patient-specific anatomy, and improve long-term functional outcomes,” said Jared D. Ament, MD, MPH, FAANS, FACS. “Nivalon’s platform represents a groundbreaking convergence of AI-driven surgical planning, personalized implant design, advanced ceramic biomaterials, and additive manufacturing. This technology has the potential to significantly advance the field of motion preservation and redefine how spinal reconstruction is approached for future patients.”
Nivalon Medical Technologies is currently developing a fully patient-specific lumbar total disc replacement system utilizing advanced ceramic 3D printing and elastomeric core technology designed to restore spinal alignment, preserve physiologic motion, and reduce imaging artifacts commonly associated with traditional metallic spinal implants.
About Nivalon Medical Technologies Inc.
Nivalon Medical Technologies Inc. is a medical technology company focused on the development of personalized spinal implant systems designed to preserve motion, restore anatomy, and improve patient outcomes through advanced imaging, AI-driven surgical planning, and additive manufacturing technologies.
Nivalon Medical Technologies Inc. Appoints Jared D. Ament, MD, MPH, FAANS, FACS as Chief Medical Officer